TASOR Polyclonal antibody

TASOR Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

Human

Applications

WB, ELISA

Conjugate

Unconjugated

Cat no : 30188-1-AP

Synonyms

C3orf63, CTCL tumor antigen se89 1, DKFZp686C2456, FAM208A, KIAA1105, RAP140, se89 1, TASOR



Tested Applications

Positive WB detected inHeLa cells, HepG2 cells, Jurkat cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

30188-1-AP targets TASOR in WB, ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen TASOR fusion protein Ag32757
Full Name chromosome 3 open reading frame 63
Calculated Molecular Weight189 kDa
Observed Molecular Weight189 kDa
GenBank Accession NumberNM_001112736.1
Gene Symbol C3orf63
Gene ID (NCBI) 23272
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

TASOR, also known as FAM208A or C3orf63, is the central subunit of the human silencing hub (HUSH) complex. HUSH regulates deposition of the epigenetic mark H3K9me3. TASOR has a catalytically-inactive PARP domain which is necessary for targeted H3K9me3 deposition (PMID: 33009411). TASOR and the RNA deadenylase CCR4-NOT complex scaffold CNOT1 synergistically repress HIV proviral expression (PMID: 35013187). TASOR affects the genome stability during the cellular division and also interacts with methylation complex in adult tissues (PMID: 34272044).

Protocols

Product Specific Protocols
WB protocol for TASOR antibody 30188-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols